Teva withdraws Shield patent oppositions
19-10-2020
European Commission calls out Teva over anti-competitive practice
18-07-2017
EIP hires Teva litigator
07-01-2014
ESB Professional / shutterstock.com
Drug company Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the EU General Court ruled in favour of the European Union IP Office (EUIPO) yesterday, July 8.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Teva, EU General Court, EUIPO, trademark, migraine, goods, slogan, ‘French, public, company
